The share price of Mazor Robotics Ltd. (TASE:MZOR) rose 11.5% today, after rising 8.5% yesterday, to NIS 15.59, giving a market cap of NIS 500 million, after announcing sales of its Renaissance robotic spinal surgical guidance systems in Taiwan and Texas.
Today, Mazor announced that its Taiwanese distributor, Pinnaclemed Co. Ltd., bought its first Renaissance system, which will be installed at a hospital during the second quarter. The Taiwan Food and Drug Administration approved the Renaissance system in January. Mazor has already installed Renaissance systems in Japan, China, Korea, India, Singapore, Vietnam, and Australia. Mazor CEO Ori Hadomi said, "We expect Taiwan to offer strong growth prospects for Renaissance in the coming years."
Yesterday, Mazor sold its first Renaissance system to Westside Surgical Hospital in Houston, marking the company's seventh sale in Texas and 21st sale in the US. Hadomi said, "We expect the system to be used in at least eight cases during its initial installation period of two weeks."
Published by Globes [online], Israel business news - www.globes-online.com - on March 28, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013